Metamizole

Generic Name
Metamizole
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C13H17N3O4S
CAS Number
50567-35-6
Unique Ingredient Identifier
934T64RMNJ
Background

Metamizole (dipyrone) is a pyrazolone derivative that belongs to the group of nonacid nonopioids. It is considered a potent analgesic and antipyretic with favourable gastrointestinal tolerability. Metamizole was formerly marketed in the US as Dimethone tablets and injection, Protemp oral liquid, and other drug products, and was withdrawn due to its associati...

Indication

Metamizole is banned in several countries, where it was previously used as a powerful analgesic and fever reducer. In countries where it is still available, metamizole is indicated for acute severe pain after injuries or surgeries, colic, tumor pain, and acute or severe pain symptoms, as well as high fever if other treatments are unsuccessful.

Associated Conditions
Severe Pain, Severe Fever
Associated Therapies
-

Comparing Protocols for Analgesia Following Elective Cesarean Section

First Posted Date
2018-08-09
Last Posted Date
2018-08-09
Lead Sponsor
Wolfson Medical Center
Target Recruit Count
120
Registration Number
NCT03622489
Locations
🇮🇱

Wolfson medical center, Holon, Israel

TAP vs QLB in Patients After Cesarean Delivery

First Posted Date
2018-01-19
Last Posted Date
2023-11-24
Lead Sponsor
Medical University of Lublin
Target Recruit Count
105
Registration Number
NCT03404908
Locations
🇵🇱

II Department of Anesthesia and Intensive Care, Medical University of Lublin, Lublin, Poland

Paracetamol and Metamizole With SPI-guided Anaesthesia for VRS

First Posted Date
2018-01-03
Last Posted Date
2023-12-15
Lead Sponsor
Medical University of Silesia
Target Recruit Count
165
Registration Number
NCT03389243
Locations
🇵🇱

Medical University of Silesia, Sosnowiec, Silesia, Poland

The Effect of Gabapentin Used as a Preemptive to the Emergence and Development Chronic Neuropathic Pain in Patients After Spinal Cord Trauma

First Posted Date
2017-08-21
Last Posted Date
2019-03-07
Lead Sponsor
Masaryk University
Registration Number
NCT03255330
Locations
🇨🇿

Fakultní nemocnice Brno, Brno, Czechia

Regional Analgesia After Cesarean Section

First Posted Date
2017-08-09
Last Posted Date
2020-02-18
Lead Sponsor
Medical University of Lublin
Target Recruit Count
105
Registration Number
NCT03244540
Locations
🇵🇱

Szpital Specjalistyczny PRO-FAMILIA w Rzeszowie, Rzeszów, Poland

🇵🇱

Szpital Kliniczny Dzieciątka Jezus, Warszawa, Poland

SPI-directed Analgesia for Vitreoretinal Surgeries

First Posted Date
2016-11-25
Last Posted Date
2018-01-23
Lead Sponsor
Medical University of Silesia
Target Recruit Count
176
Registration Number
NCT02973581
Locations
🇵🇱

Medical University of Silesia, Sosnowiec, Silesia, Poland

SPI-directed Analgesia for Lumbar Discectomy

First Posted Date
2016-11-23
Last Posted Date
2019-04-16
Lead Sponsor
Medical University of Silesia
Target Recruit Count
132
Registration Number
NCT02971540
Locations
🇵🇱

Medical University of Silesia, Sosnowiec, Silesia, Poland

Comparison of Two Pain-treatment Techniques After Cesarean Section

First Posted Date
2016-06-17
Last Posted Date
2023-11-28
Lead Sponsor
Michał Borys
Target Recruit Count
232
Registration Number
NCT02804126
Locations
🇵🇱

II Department of Anesthesia and Intensive Care, Lublin, Poland

Optimal Analgesia in Acute Gastroenteritis

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2016-03-17
Last Posted Date
2016-03-17
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
15
Registration Number
NCT02711241
Locations
🇮🇱

Hadssah Medical Organisation, Jerusalem, Israel

Delirium in Elderly Patients With Trauma of the Hip

First Posted Date
2016-02-23
Last Posted Date
2023-08-04
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Target Recruit Count
239
Registration Number
NCT02689024
Locations
🇳🇱

Meander Medical Center, Amersfoort, Netherlands

🇳🇱

VU Medical Center, Amsterdam, Netherlands

🇳🇱

Academic Medical Center, Amsterdam, Netherlands

and more 2 locations
© Copyright 2024. All Rights Reserved by MedPath